European Stocks Reach Record Highs Driven by Novo Nordisk Surge

Brussels | EcoPulse24

European stocks recorded limited gains during today's trading session, with the STOXX 50 index up around 0.1% and the STOXX 600 rising by 0.3% to reach a new all-time high, rebounding quietly after a slightly negative session the previous day.

Novo Nordisk led the gains, with its shares surging nearly 6% following the U.S. FDA's approval to market an oral version of its popular obesity drug Wegovy in the United States. This move expands the drug's market reach and supports the company's growth prospects.

Other major pharmaceutical companies also benefited: AstraZeneca shares rose about 0.8%, Novartis climbed 0.7%, and Roche added approximately 0.6%.

In addition to healthcare, defensive sectors such as telecommunications and financial services contributed to the market's strength, as investors continued to favor stocks with stable cash flows amid ongoing global market uncertainty.

The current performance reflects the resilience of European markets and ongoing capital inflows into leading stocks, with investors focusing on companies with strong operational momentum, particularly in the pharmaceutical sector, which continues to play a pivotal role in driving indices to historic highs.